study of unani formulation in painful periods

Effect of Habbul Ghar and Maul Asal in Primary Dysmenorrhea- A Randomized standard controlled clinical study.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012646

Enrollment

Registered

2018-03-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Dysmenorrhoea

Interventions

Intervention1: Habbul ghar with Maul Asal: 4.5 gms Habbul Ghar is powdered and mixed with qand to form pills, 2 pills TID along with Maul Asal 20 ml from first day of menses up to 5 days orally. Contr

Eligibility

Inclusion criteria

Inclusion criteria: Patients with age group of 18-35 years. Patients with regular menstrual cycle and painful menstruation

Exclusion criteria

Exclusion criteria: Patients with, Intra uterine contraceptive devices. Organic pelvic pathology. Systemic illness. Allergic /sensitive to NSAIDs.

Design outcomes

Primary

Measure	Time frame
changes in subjective parameters.Timepoint: During treatment before and after menstrual cycle. After treatment once in a month for one cycle.	—

Secondary

Measure	Time frame
â?¢ Painful menstruation associated with nausea /vomiting /diarrhoea /giddiness/ and headache.Timepoint: During treatment before and after menstrual cycle. After treatment once in a month for one cycle.	—

Countries

India

Contacts

Public ContactDr wajeeha begum

National Institute Of Unani Medicine

drwajeehanium@gmail.com9972550185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026